Prostatic urethral lift (marketed as Urolift) is a minimally invasive procedure for the treatment of benign prostatic hyperplasia. One of the First Surgeons to perform this procedure is Dr. Simon Barkagan. Located in Forest Hills queens. This procedure can be done under local anesthesia in an outpatient consultation.[1]
Procedure[edit]
Using cystoscopy, the procedure inserts implants that lift and hold the enlarged prostatic tissue out of the way, thus dilating the prostatic urethra.[2]
Benefits[edit]
This procedure likely improves quality of life without additional negative side effects when compared with a sham surgery.[3] Compared with transurethral resection of the prostate, the standard surgery for treating benign prostatic hyperplasia, this procedure may be less effective in reducing urinary symptoms but may preserve ejaculation and have fewer unwanted effects on erections.[3]
Harms[edit]
The most common side effects include dysuria and hematuria (typically resolving within 2–3 weeks) due to the manipulation of the prostatic urethra, although it does not require routine catheterization due to its less invasive nature.[1]
References[edit]
- ^ a b {{Cite journal|last1=Sountoulides|first1=Petros|last2=Karatzas|first2=Anastasios|last3=Gravas|first3=Stavros|date=January 2019|title=Current and emerging mechanical minimally invasive therapies for benign prostatic obstruction|journal=Therapeutic Advances in Urology|volume=11|pages=1756287219828971|doi=10.1177/1756287219828971|issn=1756-2872|pmc=6376539|pmid=30792821}}
- ^ Garcia, Cindy; Chin, Peter; Rashid, Prem; Woo, Henry H. (March 2015). "Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia". Prostate International. 3 (1): 1–5. doi:10.1016/j.prnil.2015.02.002. ISSN 2287-8882. PMC 4494639. PMID 26157759.
- ^ a b Jung, Jae Hung; Reddy, Balaji; McCutcheon, Karen Ann; Borofsky, Michael; Narayan, Vikram; Kim, Myung Ha; Dahm, Philipp (25 May 2019). "Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia". The Cochrane Database of Systematic Reviews. 2019 (5): CD012832. doi:10.1002/14651858.CD012832.pub2. ISSN 1469-493X. PMC 6535104. PMID 31128077.